AVROBIO

AVRO

AVRO AVROBIO NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    AVRO Chart
    See on advanced chart >

    About

    AVROBIO, Inc. was formed as a corporation under the laws of the State of Delaware in November 2015.They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases...
    • Highlight
      A company that developing step-change cell and gene therapies for the treatment of cancer
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      06/21/2018
    • Established Date
      Invalid Date
    • Full-time Employees
      13
    • Address
      One Broadway Fourteenth Floor Cambridge Massachusetts 02142
    • Tel
      1-617-9148420
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock